This inventor holds 2 USPTO granted patents. Top assignee: Valneva Austria Gmbh. Active years: 2014-2016.
Company Filing History:
Years Active: 2014-2016
Title: The Innovative Contributions of Karin Riedl
Introduction
Karin Riedl is a notable inventor based in Krems, Austria. She has made significant contributions to the field of pharmaceuticals, particularly through her innovative work on nanoparticles. With a total of 2 patents to her name, Riedl's inventions are paving the way for advancements in medical treatments.
Latest Patents
Riedl's latest patents include the development of IC31 nanoparticles. This invention discloses pharmaceutical compositions in liquid form that comprise a peptide with the amino acid sequence KLKLKLK and an oligodeoxynucleotide with the nucleic acid sequence (dIdC). The peptide and the oligodeoxynucleotide are present as sterile-filterable nanoparticles in the composition, forming a suspension characterized by a mean particle size of the solid particles being less than 1 µm. This innovative approach has the potential to enhance the efficacy of pharmaceutical formulations.
Career Highlights
Karin Riedl is currently employed at Valneva Austria GmbH, where she continues to push the boundaries of pharmaceutical research. Her work focuses on developing novel therapeutic solutions that can significantly impact patient care and treatment outcomes.
Collaborations
Throughout her career, Riedl has collaborated with talented individuals such as Benjamin Wizel and Karen Lingnau. These partnerships have fostered a creative environment that encourages innovation and the sharing of ideas.
Conclusion
Karin Riedl's contributions to the field of pharmaceuticals through her patents and collaborations highlight her role as a leading inventor. Her work with nanoparticles is set to make a lasting impact on medical science and patient treatment.